PMC Links for GEO Profiles (Select 73110795) - PMC

Masashi Takawa, Ken Masuda, Masaki Kunizaki, Yataro Daigo, Katsunori Takagi, Yukiko Iwai, Hyun‐Soo Cho, Gouji Toyokawa, Yuka Yamane, Kazuhiro Maejima, Helen I. Field, Takaaki Kobayashi, Takayuki Akasu, Masanori Sugiyama, Eijyu Tsuchiya, Yutaka Atomi, Bruce A. J. Ponder, Yusuke Nakamura, Ryuji Hamamoto

Cancer Sci. 2011 Jul; 102(7): 1298–1305. Published online 2011 May 26. doi: 10.1111/j.1349-7006.2011.01958.x

PMCID:: PMC11159278

Abstract Article PDF–563K

Select item 110479204.

Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells

Mevan Jacksi, Eva Schad, Agnes Tantos

Biomolecules. 2024 Apr; 14(4): 445. Published online 2024 Apr 5. doi: 10.3390/biom14040445

PMCID:: PMC11047920

Abstract Article PDF–3.7M

Select item 110374055.

MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2

Hui Yu, Xianrong Xu, Lirong Zhu, Shengjie Chen, Jincheng He

J Cell Mol Med. 2024 Apr; 28(8): e18216. Published online 2024 Apr 23. doi: 10.1111/jcmm.18216

PMCID:: PMC11037405

Abstract Article PDF–12M

Select item 109804446.

Role of EZH2 in adipogenesis and obesity: Current state of the art and implications – A review

Haixia Wang

Medicine (Baltimore) 2022 Sep 9; 101(36): e30344. Published online 2022 Sep 9. doi: 10.1097/MD.0000000000030344

PMCID:: PMC10980444

Abstract Article PDF–988K

Select item 109249677.

MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2

Abarna Sinha, Abhisikta Ghosh, Arnab Ghosh, Sonia Mathai, Jaydip Bhaumik, Asima Mukhopadhyay, Arindam Maitra, Nidhan K. Biswas, Sharmila Sengupta

Clin Epigenetics. 2024; 16: 40. Published online 2024 Mar 10. doi: 10.1186/s13148-024-01651-9

PMCID:: PMC10924967

Abstract Article PDF–3.7M

Select item 108634878.

EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas

Tanner J. DuCote, Xiulong Song, Kassandra J. Naughton, Fan Chen, Daniel R. Plaugher, Avery R. Childress, Abigail R. Gellert, Erika M. Skaggs, Xufeng Qu, Jinze Liu, Jinpeng Liu, Fei Li, Kwok-Kin Wong, Christine F. Brainson

Cancer Res Commun. 2024 Feb; 4(2): 388–403. Published online 2024 Feb 13. doi: 10.1158/2767-9764.CRC-23-0399

PMCID:: PMC10863487

Abstract Article PDF–20M

Select item 108351319.

Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic

Yunyun Guo, Rui Cheng, Yuqing Wang, Maria E. Gonzalez, Hongshan Zhang, Yang Liu, Celina G. Kleer, Lixiang Xue

eBioMedicine. 2024 Feb; 100: 104972. Published online 2024 Jan 19. doi: 10.1016/j.ebiom.2024.104972

PMCID:: PMC10835131

Abstract Article PDF–1.4M

Select item 1075610410.

Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway

Guanli Liang, Lei Han, Ming Qu, Jun Xue, Dandan Xu, Xueliang Wu, Yonggang Lu

Aging (Albany NY) 2023 Dec 15; 15(23): 13655–13668. Published online 2023 Dec 2. doi: 10.18632/aging.205197

PMCID:: PMC10756104

Abstract Article PDF–2.1M

Select item 1074935711.

Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas

Evelin Makk, Noémi Bohonyi, Angéla Oszter, Klára Éles, Tamás Tornóczky, Arnold Tóth, Endre Kálmán, Krisztina Kovács

Pathol Oncol Res. 2023; 29: 1611547. Published online 2023 Dec 11. doi: 10.3389/pore.2023.1611547

PMCID:: PMC10749357

Abstract Article PDF–2.5M

Select item 1073190412.

Long non-coding RNA SNHG4 aggravates cigarette smoke-induced COPD by regulating miR-144-3p/EZH2 axis

Benyan Song, Yusi Chen

BMC Pulm Med. 2023; 23: 513. Published online 2023 Dec 19. doi: 10.1186/s12890-023-02818-5

PMCID:: PMC10731904

Abstract Article PDF–3.8M

Select item 1068565713.

EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma

Boheng Li, Qidi Zhou, Qin Wan, Xuan Qiao, Shangying Chen, Jianbiao Zhou, Zhijun Wuxiao, Lei Luo, Siok-Bian Ng, Jieping Li, Wee-Joo Chng

Clin Epigenetics. 2023; 15: 187. Published online 2023 Nov 29. doi: 10.1186/s13148-023-01606-6

PMCID:: PMC10685657

Abstract Article PDF–8.3M

Select item 1068022014.

EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A

Ke Wang, Xunliang Jiang, Yu Jiang, Jun Liu, Yongtao Du, Zecheng Zhang, Yunlong Li, Xinhui Zhao, Jipeng Li, Rui Zhang

J Exp Clin Cancer Res. 2023; 42: 320. Published online 2023 Nov 27. doi: 10.1186/s13046-023-02855-2

PMCID:: PMC10680220

Abstract Article PDF–11M

Select item 1065304815.

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma

Marlies Vanden Bempt, Koen Debackere, Sofie Demeyer, Quentin Van Thillo, Nienke Meeuws, Cristina Prieto, Sarah Provost, Nicole Mentens, Kris Jacobs, Olga Gielen, David Nittner, Seishi Ogawa, Keisuke Kataoka, Carlos Graux, Thomas Tousseyn, Jan Cools, Daan Dierickx

Blood. 2022 Dec 8; 140(23): 2463–2476. Published online 2022 Aug 16. doi: 10.1182/blood.2022016428

PMCID:: PMC10653048

Abstract Article

Select item 1056379916.

EZH2 expression is associated with inferior overall survival in mantle cell lymphoma

Diana Martinez-Baquero, Ali Sakhdari, Huan Mo, Do Hwan Kim, Rashmi Kanagal-Shamanna, Shaoying Li, Ken H. Young, Dennis P. O’Malley, Ahmet Dogan, Preetesh Jain, Michael L. Wang, Timothy J. McDonnell, Roberto N. Miranda, Francisco Vega, L. Jeffrey Medeiros, Chi Young Ok

Mod Pathol. Author manuscript; available in PMC 2023 Oct 10.

Published in final edited form as: Mod Pathol. 2021 Dec; 34(12): 2183–2191. Published online 2021 Aug 10. doi: 10.1038/s41379-021-00885-9

PMCID:: PMC10563799

Abstract Article PDF–2.3M

Select item 1055726717.

Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner

Feng Yu, Lili Li, Mengwen Zhang, Shanshan Sun

BMC Cancer. 2023; 23: 948. Published online 2023 Oct 6. doi: 10.1186/s12885-023-11450-9

Correction in:: BMC Cancer. 2023; 23: 1176.

PMCID:: PMC10557267

Abstract Article PDF–12M

Select item 1053917018.

Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma

Anuvrat Sircar, Satishkumar Singh, Zijun Y. Xu-Monette, Krysta Mila Coyle, Laura K. Hilton, Evangelia Chavdoula, Parvathi Ranganathan, Neeraj Jain, Walter Hanel, Philip Tsichlis, Lapo Alinari, Blake R. Peterson, Jianguo Tao, Natarajan Muthusamy, Robert Baiocchi, Narendranath Epperla, Ken H. Young, Ryan Morin, Lalit Sehgal

Leukemia. 2023; 37(10): 2094–2106. Published online 2023 Aug 19. doi: 10.1038/s41375-023-02006-8